R6-PURE (GHRP-6) by Meditech is a pharmaceutical-grade Growth Hormone Releasing Peptide-6 formulated as a lyophilized injectable peptide at 5 mg per vial. GHRP-6 is a synthetic hexapeptide with an established research history in neuroendocrinological and peptide pharmacology literature, investigated for its capacity to stimulate endogenous growth hormone secretion through ghrelin receptor activation — a mechanistically distinct approach to growth hormone modulation relative to exogenous somatropin administration.
 
✔ Key Research Insights
Studied for its role as a ghrelin receptor agonist, with documented stimulation of pituitary growth hormone secretion in research subjects via activation of the growth hormone secretagogue receptor (GHS-R) in neuroendocrinological research
Investigated for its downstream effects on IGF-1 production following GH stimulation, with associated influences on lean mass parameters and tissue repair mechanisms documented in peptide pharmacology observations
Researched for its influence on metabolic parameters and body composition indices in clinical observations, mediated through growth hormone secretagogue activity in documented subject populations
Examined for its effects on recovery markers, sleep architecture quality, and connective tissue parameters including joint and tendon health across peptide research literature
Documented for its appetite-stimulating properties via ghrelin receptor activation, a pharmacological characteristic of clinical relevance noted consistently across GHRP-6 research relative to other growth hormone releasing peptides
Manufactured by Meditech to pharmaceutical-grade purity and lyophilized peptide formulation standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: R6-PURE
Molecule: Growth Hormone Releasing Peptide-6 (GHRP-6)
Concentration: 5 mg per vial
Appearance: Lyophilized white powder
Form: Injectable peptide requiring reconstitution prior to administration
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
GHRP-6 is a synthetic hexapeptide that functions as a selective agonist at the growth hormone secretagogue receptor type 1a (GHS-R1a) — also known as the ghrelin receptor — located in the hypothalamus and pituitary gland. In research subjects, binding of GHRP-6 to GHS-R1a produces two complementary effects on the growth hormone axis: direct stimulation of pituitary somatotroph cells to release endogenous growth hormone, and suppression of somatostatin — the endogenous inhibitor of GH release — at the hypothalamic level. The resulting elevation of circulating growth hormone subsequently stimulates hepatic IGF-1 production, with downstream effects on protein synthesis, cellular regeneration, and metabolic regulation documented across peptide pharmacology research literature. GHRP-6 is distinguished from other growth hormone releasing peptides in research literature by its particularly pronounced appetite-stimulating effect, attributed to its agonist activity at peripheral ghrelin receptors involved in appetite and energy balance regulation — a pharmacological characteristic of clinical relevance in subject populations where appetite stimulation is a research consideration. Reconstitution with bacteriostatic water is standard protocol prior to subcutaneous administration in documented research settings, with lyophilized storage ensuring peptide stability and bioactivity prior to use.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and lyophilized peptide formulation standards
Ghrelin receptor agonist with a well-documented neuroendocrinological mechanism of action, stimulating endogenous growth hormone secretion rather than introducing exogenous somatropin
Distinct pharmacological profile relative to other GHRP compounds, with particularly noted appetite-stimulating activity documented across comparative peptide research literature
Widely referenced in neuroendocrinological and peptide pharmacology research under the GHRP-6 and growth hormone secretagogue designations
Available in lyophilized vial format requiring reconstitution prior to subcutaneous administration per standard peptide research protocols